Citations in PubMed

Primary Citation PubMed: 2125487 Citations in PubMed

PDB ID Mentions in PubMed Central Article count: 4

Citations in PubMed

This linkout lists citations, indexed by PubMed, to the Primary Citation for this PDB ID.

PDB ID Mentions in PubMed Central

Data mentions are occurrences of PDB IDs in the full text articles from the PubMedCentral Open Access Subset of currently about 1 million articles. For each article, the sentences containing the PDB ID are listed. Article titles can be filtered by keywords and sorted by year.

  • 3 per page
  • 5 per page
  • 10 per page
  • view all
  • Publication Year
  • Ascending
  • Descending

Isolation, cloning and structural characterisation of boophilin, a multifunctional Kunitz-type proteinase inhibitor from the cattle tick.

(2008) PLoS One 3

PubMed: 18286181 | PubMedCentral: PMC2230226 | DOI: 10.1371/journal.pone.0001624

Also included in the alignment are the sequences of BPTI and of the closest related human Kunitz modules structurally characterised so far (two copies, one aligned with each Kunitz module of boophilin... : The second and third TFPI domains (1TFX [6] and 1IRH [75] , respectively), the single Kunitz domain of APP (1AAP) [39] , and the C-terminal Kunitz domain of type VI collagen (2KNT) [76] .

Publication Year: 2008


Computational protein design: validation and possible relevance as a tool for homology searching and fold recognition.

(2010) PLoS One 5

PubMed: 20463972 | PubMedCentral: PMC2864755 | DOI: 10.1371/journal.pone.0010410

SKIs __________ Chemokines __________ PDZ domains __________ Caspases __________ PDB code Identity PDB code Identity PDB code Identity PDB code Identity 4pti 37.4 1ilq 30.3 1pdr 36.0 1nme 31.0 2knt 42... 2 1plf 31.3 1kwa 22.8 1m72 31.6 1tfx 41.8 1msg 25.6 2fe5 36.3 1pyo 37.5 1aap 42.6 1hum 32.4 1be9 32.5 1i51 32.1 1bik 42.6 1vmp 32.2 1qav 29.7 1qdu 28.7 1dtx 37.3 1rto 40.1 1nte 24.2 1nw9 41.9 1bun 37.1 1dom 26.0 1l6o 31.7 1dem 41.9 1eig 27.9 1qau 30.3 1g2s 26.5 1g9o 35.4 1j9o 18.2 1ihj 28.6 1nr2 38.7 1n7f 30.5 1nap 30.7 2h3l 36.2 1n7e 30.9 1q3o 35.6 2f5y 35.6 2fne 35.2 2byg 36.5 Mean 40.4 30.3 32.3 33.8 a Mean identity of the 8.000 lowest-energy designed sequences relative to each corresponding native template.

Publication Year: 2010


Copper binding to the Alzheimer's disease amyloid precursor protein.

(2008) Eur Biophys J 37

PubMed: 18030462 | PubMedCentral: PMC2921068 | DOI: 10.1007/s00249-007-0234-3

The N-terminal growth factor domain (GFD; PDB id: 1MWP) is followed by CuBD (PDB ids: 1OWT, 2FKL, 2FJZ and 2FK3), an acidic-rich region, Kunitz-type protease inhibitor (KPI; PDB id: 1AAP) and OX2 doma... ns that occur in some APP isoforms, a couple of glycosylated domains (D6a, sometimes called the E2 domain or CAPPD; PDB ids: 1TKN, 1RW6; followed by an unstructured domain we refer to as D6b), a transmembrane region (TM) and a cytoplasmic tail.

Publication Year: 2008


Alzheimer's disease--a panorama glimpse.

(2014) Int J Mol Sci 15

PubMed: 25032844 | PubMedCentral: PMC4139864 | DOI: 10.3390/ijms150712631

PDB ID Experimental Technique Resolution Release Date Residues Count DOI 1AAP [ 59 ] X-RAY DIFFRACTION 1.5 1991-10-15 116 - 1BRC [ 60 ] X-RAY DIFFRACTION 2.5 1994-05-31 279 10.1006/jmbi.1993.1211 1TAW... [ 61 ] X-RAY DIFFRACTION 1.8 1997-06-24 281 10.1002/pro.5560060902 1CA0 [ 61 ] X-RAY DIFFRACTION 2.1 1997-07-23 590 10.1002/pro.5560060902 1X11 [ 62 ] X-RAY DIFFRACTION 2.5 1998-01-14 370 10.1093/emboj/16.20.6141 1MWP [ 63 ] X-RAY DIFFRACTION 1.8 2000-03-15 96 10.1038/7562 1OQN [ 64 ] X-RAY DIFFRACTION 2.3 2003-08-05 336 10.1074/jbc.M304384200 1OWT [ 65 ] SOLUTION NMR - 2003-05-13 66 10.1074/jbc.M300629200 1TKN [ 66 ] SOLUTION NMR - 2004-08-03 110 10.1021/bi049041o 1ZJD [ 67 ] X-RAY DIFFRACTION 2.6 2005-08-09 294 10.1074/jbc.M504990200 2BEG [ 68 ] SOLUTION NMR - 2005-11-22 210 10.1073/pnas.0506723102 2G47 [ 69 ] X-RAY DIFFRACTION 2.1 2006-10-24 2060 10.1038/nature05143 2FJZ [ 70 ] X-RAY DIFFRACTION 1.61 2007-01-16 59 10.1016/j.jmb.2006.12.041 2FK1 [ 70 ] X-RAY DIFFRACTION 1.6 2007-01-16 59 10.1016/j.jmb.2006.12.041 2FK2 [ 70 ] X-RAY DIFFRACTION 1.65 2007-01-16 59 10.1016/j.jmb.2006.12.041 2FK3 [ 70 ] X-RAY DIFFRACTION 2.4 2007-01-16 472 10.1016/j.jmb.2006.12.041 2FKL [ 70 ] X-RAY DIFFRACTION 2.5 2007-01-16 132 10.1016/j.jmb.2006.12.041 2FMA [ 71 ] X-RAY DIFFRACTION 0.85 2007-01-16 59 10.1107/S1744309107041139 2IPU [ 72 ] X-RAY DIFFRACTION 1.65 2007-10-09 906 10.1073/pnas.0705888104 2R0W [ 72 ] X-RAY DIFFRACTION 2.5 2007-10-16 450 10.1073/pnas.0705888104 2OTK [ 58 ] SOLUTION NMR - 2008-02-12 182 10.1073/pnas.0711731105 2ROZ [ 73 ] SOLUTION NMR - 2008-07-22 168 10.1074/jbc.M803892200 3BAE [ 74 ] X-RAY DIFFRACTION 1.59 2008-04-15 474 10.1016/j.jmb.2007.12.036 3BKJ [ 74 ] X-RAY DIFFRACTION 1.59 2008-04-15 492 10.1016/j.jmb.2007.12.036 3DXC [ 75 ] X-RAY DIFFRACTION 2.1 2008-09-16 350 10.1038/embor.2008.188 3DXD [ 75 ] X-RAY DIFFRACTION 2.2 2008-09-16 350 10.1038/embor.2008.188 3DXE [ 75 ] X-RAY DIFFRACTION 2.0 2008-09-16 350 10.1038/embor.2008.188 3GCI [ 76 ] X-RAY DIFFRACTION 2.04 2009-03-10 126 - 3IFL [ 77 ] X-RAY DIFFRACTION 1.5 2009-11-17 448 10.1074/jbc.M109.045187 3IFN [ 77 ] X-RAY DIFFRACTION 1.5 2009-11-17 481 10.1074/jbc.M109.045187 3IFO [ 77 ] X-RAY DIFFRACTION 2.15 2009-11-17 904 10.1074/jbc.M109.045187 3IFP [ 77 ] X-RAY DIFFRACTION 2.95 2009-11-17 1808 10.1074/jbc.M109.045187 3JQ5 [ 76 ] X-RAY DIFFRACTION 2.03 2009-09-29 127 - 3JQL [ 76 ] X-RAY DIFFRACTION 1.2 2009-09-29 125 - 2WK3 [ 78 ] X-RAY DIFFRACTION 2.59 2009-11-03 2122 10.1016/j.jmb.2009.10.072 3KTM [ 79 ] X-RAY DIFFRACTION 2.7 2010-02-23 1528 10.1073/pnas.0911326107 3L81 [ 80 ] X-RAY DIFFRACTION 1.6 2010-06-02 308 10.1016/j.devcel.2010.01.015 3JTI [ 81 ] X-RAY DIFFRACTION 1.8 2010-07-21 127 - 3L33 [ 82 ] X-RAY DIFFRACTION 2.48 2010-09-22 1104 10.1074/jbc.M110.171348 3MOQ [ 83 ] X-RAY DIFFRACTION 2.05 2011-02-16 504 10.1523/JNEUROSCI.4259-10.2011 3MXC [ 84 ] X-RAY DIFFRACTION 2.0 2011-05-11 110 10.1016/j.jmb.2011.09.046 3NYJ [ 85 ] X-RAY DIFFRACTION 3.2 2011-06-01 207 10.1021/bi101846x 3NYL [ 86 ] X-RAY DIFFRACTION 2.8 2011-07-13 210 10.1016/j.molcel.2004.06.037 2Y3J [ 87 ] X-RAY DIFFRACTION 1.99 2011-11-02 48 10.1073/pnas.1112600108 2Y3K [ 87 ] X-RAY DIFFRACTION 1.9 2011-11-02 64 10.1073/pnas.1112600108 3AYU [ 88 ] X-RAY DIFFRACTION 2.0 2011-08-03 177 10.1074/jbc.M111.264176 2LMN [ 89 ] SOLID-STATE NMR - 2011-12-28 480 10.1021/bi051952q 2LMO [ 89 ] SOLID-STATE NMR - 2011-12-28 480 10.1021/bi051952q 2LMP [ 90 ] SOLID-STATE NMR - 2011-12-28 720 10.1073/pnas.0806270105 2LMQ [ 90 ] SOLID-STATE NMR - 2011-12-28 720 10.1073/pnas.0806270105 2LNQ [ 91 ] SOLID-STATE NMR - 2012-02-08 320 10.1073/pnas.1111305109 2LOH [ 92 ] SOLUTION NMR - 2012-05-23 86 10.1016/j.febslet.2012.04.062 2LP1 [ 93 ] SOLUTION NMR - 2012-06-06 122 10.1126/science.1219988 2LLM [ 94 ] SOLUTION NMR - 2012-06-20 43 PMCID: PMC3347594 3U0T [ 95 ] X-RAY DIFFRACTION 2.5 2012-01-11 894 10.1016/j.jmb.2011.11.047 3UMH [ 96 ] X-RAY DIFFRACTION 2.0 2012-01-25 211 10.1016/j.jmb.2011.12.057 3UMI [ 96 ] X-RAY DIFFRACTION 2.4 2012-01-25 211 10.1016/j.jmb.2011.12.057 3UMK [ 96 ] X-RAY DIFFRACTION 2.6 2012-01-25 211 10.1016/j.jmb.2011.12.057 3SV1 [ 97 ] X-RAY DIFFRACTION 3.3 2012-07-11 612 10.1093/jmcb/mjs033 4HIX [ 98 ] X-RAY DIFFRACTION 2.2 2013-03-13 475 10.1038/srep01302 2M4J [ 99 ] SOLUTION NMR - 2013-09-25 360 10.1016/j.cell.2013.08.035 2LZ3 [ 100 ] SOLUTION NMR - 2013-10-02 56 - 2LZ4 [ 100 ] SOLUTION NMR - 2013-10-02 56 - The central amyloidogenic step of the oligomerization process is the transition from α -helix rich (starting from the conformation of APP before being cleavaged) to β -sheet rich structures.

Publication Year: 2014